James E. Talmadge – författare
Visar alla böcker från författaren James E. Talmadge. Handla med fri frakt och snabb leverans.
5 produkter
Screening for Biological Response Modifiers: Methods and Rationale
Av James E. Talmadge, Isaiah J. Fidler m. fl.
Inbunden, 1985
1131 kr
Lägg i varukorg
The observation in the 1950s that nitrogen mustard and other toxic chemicals could induce antitumor responses in patients with refractory lymphoma initiated a massive search for active chemotherapeutic agents. The initial observations stimulated a search for new chemotherapeutic agents which might …
Screening for Biological Response Modifiers: Methods and Rationale
Av James E. Talmadge, Isaiah J. Fidler m. fl.
Häftad, 2011
1131 kr
Lägg i varukorg
The observation in the 1950s that nitrogen mustard and other toxic chemicals could induce antitumor responses in patients with refractory lymphoma initiated a massive search for active chemotherapeutic agents. The initial observations stimulated a search for new chemotherapeutic agents which might …
Screening for Biological Response Modifiers: Methods and Rationale
Av R.K. Oldham, Isaiah J. Fidler m. fl.
E-bok, 2012
1502 kr
Lägg i varukorg
The observation in the 1950s that nitrogen mustard and other toxic chemicals could induce antitumor responses in patients with refractory lymphoma initiated a massive search for active chemotherapeutic agents. The initial observations stimulated a search for new chemotherapeutic agents which might …
Myeloid-Derived Suppressor Cells and Cancer
Av David Escors, James E. Talmadge m. fl.
Häftad, 2016
569 kr
Lägg i varukorg
The book starts with an introduction to and history of myeloid-derived suppressor cells (MDSCs), followed by a description of their differentiation, their role in the tumour microenvironment and their therapeutic targeting. It closes with an outlook on future developments. In cancer patients, …
Myeloid-Derived Suppressor Cells and Cancer
Av Grazyna Kochan, Jo A. Van Ginderachter m. fl.
E-bok, 2016
739 kr
Lägg i varukorg
The book starts with an introduction to and history of myeloid-derived suppressor cells (MDSCs), followed by a description of their differentiation, their role in the tumour microenvironment and their therapeutic targeting. It closes with an outlook on future developments. In cancer patients, …